02.12.2012 Views

View - PULSION Medical Systems SE

View - PULSION Medical Systems SE

View - PULSION Medical Systems SE

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Intensive Care Med<br />

DOI 10.1007/s00134-007-0669-0<br />

Jan Kozieras<br />

Oliver Thuemer<br />

Samir G. Sakka<br />

Received: 17 November 2006<br />

Accepted: 19 April 2007<br />

© Springer-Verlag 2007<br />

This work was presented in part at the 19th<br />

annual meeting of the European Society of<br />

Intensive Care Medicine, 24–27 September<br />

2006, Barcelona.<br />

Samir Sakka has received fees from Pulsion<br />

<strong>Medical</strong> <strong>Systems</strong> AG, Munich, Germany,<br />

for giving lectures.<br />

J. Kozieras · O. Thuemer<br />

Friedrich-Schiller-University of Jena,<br />

Department of Anesthesiology and Intensive<br />

Care Medicine,<br />

Jena, Germany<br />

S. G. Sakka (✉)<br />

<strong>Medical</strong> Center Cologne-Merheim,<br />

Department of Anesthesiology and Intensive<br />

Care Medicine,<br />

Ostmerheimerstrasse 200, 51109 Cologne,<br />

Germany<br />

e-mail: sakkas@kliniken-koeln.de<br />

Tel.: +49-221-89073863<br />

Fax: +49-221-89073868<br />

Abstract Objective: The transpulmonary<br />

thermodilution technique<br />

Introduction<br />

BRIEF REPORT<br />

Transpulmonary indicator dilution techniques are increasingly<br />

being used in the intensive care unit for<br />

Influence of an acute increase in systemic<br />

vascular resistance on transpulmonary<br />

thermodilution-derived parameters<br />

in critically ill patients<br />

enables measurement of cardiac<br />

index (CI), intrathoracic blood volume<br />

(ITBV), global end-diastolic<br />

volume (GEDV), and extravascular<br />

lung water (EVLW). In this study,<br />

we analyzed the robustness of this<br />

technique during an acute increase in<br />

systemic vascular resistance (SVR).<br />

Design: Prospective, clinical study.<br />

Setting: Surgical intensive care unit<br />

in a university hospital. Patients and<br />

methods: Twenty-four mechanically<br />

ventilated septic shock patients, who<br />

for clinical indications underwent<br />

extended hemodynamic monitoring<br />

by transpulmonary thermodilution<br />

and continuously received norepinephrine.<br />

Interventions and main<br />

results: After baseline measurements,<br />

mean arterial pressure was increased<br />

briefly by increasing norepinephrine<br />

dosage and hemodynamic measurements<br />

were repeated before a control<br />

measurement was obtained. At each<br />

time point, 15 cc of 0.9% saline<br />

(< 8 °C) was administered by central<br />

venous injection in triplicate. Fluid<br />

status and respirator adjustments<br />

were kept constant. ANOVA with an<br />

all-pairwise comparison method was<br />

used for statistical analysis. Heart<br />

rate, central venous pressure, and<br />

EVLW remained constant throughout,<br />

while SVR significantly<br />

changed from 551 ± 106 to<br />

746 ± 91 dyn*s*cm –5 and again<br />

to 566 ± 138 dyn*s*cm –5 (p < 0.05).<br />

However, CI and central blood<br />

volumes showed a reversible significant<br />

increase, i.e., ITBV went from<br />

816 ± 203 to 867 ± 195 ml/m 2 and<br />

then to 821 ± 205 ml/m 2 and GEDV<br />

from 703 ± 178 to 747 ± 175 ml/m 2<br />

and finally to 704 ± 170 ml/m 2 ,<br />

respectively. In eight patients, 2-D<br />

echocardiography was applied and<br />

revealed a reversible increase in<br />

left-ventricular end-diastolic area.<br />

Conclusion: An acute increase in<br />

SVR by increasing norepinephrine<br />

dosage results in a reversible increase<br />

in central blood volumes (ITBV,<br />

GEDV) as measured by transpulmonary<br />

thermodilution and supported<br />

by echocardiography.<br />

Keywords Hemodynamic monitoring<br />

· Transpulmonary thermodilution<br />

technique · Critically ill patients<br />

hemodynamic monitoring. The transpulmonary thermodilution<br />

technique allows assessment of cardiac output<br />

and cardiac function, central blood volumes and capillary<br />

leakage. In detail, cardiac index (CI), global ejection


fraction (GEF), intrathoracic blood volume (ITBV), global<br />

end-diastolic volume (GEDV), and extravascular lung<br />

water (EVLW) may be determined.<br />

In particular, the single transpulmonary thermodilution<br />

technique has been found to be accurate for assessment<br />

of ITBV and EVLW compared with the double-indicator<br />

technique, which is regarded as the clinical reference technique<br />

[1, 2]. In general, ITBV is superior to the cardiac<br />

filling pressures for estimating cardiac preload in critically<br />

ill patients [3–6]. Furthermore, guidance of treatment by<br />

the transpulmonary indicator technique has the potential to<br />

reduce the duration of mechanical ventilation, ICU length<br />

of stay and mortality [7, 8].<br />

However, single transpulmonary thermodilution,<br />

which has been deduced from the double-indicator<br />

technique, may be prone to various problems that may<br />

occur in the clinical situation. To date, the correctness of<br />

transpulmonary thermodilution-derived ITBV and EVLW<br />

values has been confirmed during changes in cardiac<br />

output, i.e. by β-mimetic or β-blocking agents. However,<br />

acute changes in cardiac afterload, which frequently occur<br />

in critically ill patients, may also influence the accuracy of<br />

this technique. We therefore tested whether acute changes<br />

in systemic vascular resistance influences transpulmonary<br />

thermodilution-derived variables in critically ill patients<br />

requiring vasopressor support.<br />

throughout the study period. Inspiratory oxygen fraction<br />

(40 ± 10%), minute volume and airway pressures (i.e.,<br />

PEEP 10 ± 5 mbar) remained constant. Fluid status and<br />

infusion rates of other vasoactive or sedative drugs were<br />

unchanged. In eight patients, transesophageal echocardiography<br />

(TEE) (Sonos 2500, probe HP 5.0/3.7 MHz, model<br />

21364A, Hewlett Packard, CA, USA) was performed,<br />

allowing a transgastric two-dimensional short-axis<br />

view for measurement of left-ventricular end-systolic<br />

and end-diastolic areas at the mid-papillary muscle<br />

level. Echocardiography was chosen as reference, since<br />

a correlation between changes in ITBV as determined<br />

by transpulmonary thermo-dye dilution technique and<br />

left-ventricular end-diastolic area (LVEDA) has been described<br />

[9, 10]. In these eight patients, also pulse contour<br />

cardiac output (PCCO) was recorded before each bolus<br />

measurement.<br />

Statistical analysis<br />

All data are given as mean ± standard deviation (SD). Results<br />

were compared by an ANOVA on ranks for repeated<br />

measures (Friedman test) and a post-hoc all-pairwise<br />

comparison procedure (Student–Keuls method). Furthermore,<br />

linear regression analysis was used for comparison<br />

between changes in GEDV/ITBV and changes in LVEDA.<br />

Statistical significance was considered at p < 0.05. For<br />

the statistical analysis, we used SigmaStat ® for Windows<br />

(version 1.0).<br />

Patients and methods<br />

After approval from our local ethics committee and<br />

informed consent (from next-of-kin), we enrolled 24<br />

mechanically ventilated septic shock patients (16 male,<br />

8 female, age 26–71 years). All patients continuously<br />

received norepinephrine for hemodynamic support and<br />

underwent monitoring by the transpulmonary thermodilution<br />

technique (PiCCOplus ® , version 7.0 non US,<br />

Pulsion <strong>Medical</strong> <strong>Systems</strong>, Munich, Germany) for clinical<br />

indications. Patients had a femoral arterial 5-F thermistor<br />

catheter (PV20L15, Pulsion <strong>Medical</strong> <strong>Systems</strong>)<br />

and a central venous catheter (Certofix trio ® Results<br />

, Braun<br />

The patients’ average weight was 83 ± 20 kg (range<br />

56–150), height 171 ± 12 cm (range 158–204) and body<br />

surface area 2.0 ± 0.3 m<br />

Melsungen, Germany) in situ. For each measurement of<br />

CI, intrathoracic blood volume index (ITBVI), global<br />

end-diastolic volume index (GEDVI), and extravascular<br />

lung water index (EVLWI), 15 cc 0.9% saline (< 8°C)<br />

was administered by central venous injection in triplicate.<br />

Baseline values were obtained before raising mean<br />

arterial pressure (MAP) to about 90 mmHg by increasing<br />

continuous rate of norepinephrine infusion for 5 min. The<br />

second measurement was obtained during steady state at<br />

the higher MAP level. Then norepinephrine dosage was<br />

reduced to baseline conditions and a control measurement<br />

was obtained 5 min later.<br />

All patients were sedated and ventilated in a pressurecontrolled<br />

mode (BiPAP, Evita 4, Dräger, Lübeck,<br />

Germany). Respirator adjustments remained unchanged<br />

2 (range 1.6–2.9). Study patients<br />

were characterized by a mean APACHE II score of 26 ± 8<br />

(range 7–43) and SAPS II score of 51 ± 15 (range 17–73).<br />

While mean norepinephrine dosage was changed<br />

from 0.05 ± 0.04 (range 0.01–0.15) to 0.11 ± 0.09<br />

(range 0.01–0.40) and finally back to 0.05 ± 0.05 (range<br />

0.01–0.15) µg/kg/min, MAP changed from 66 ± 9 to<br />

92 ± 9 and back to 68 ± 12 mmHg. Accordingly, systemic<br />

vascular resistance (SVR) was 551 ± 106, 746 ± 91,<br />

and 566 ± 138 dyn*s*cm –5 . In parallel, systolic blood<br />

pressure increased to 139 ± 13 (median 140) mmHg.<br />

Heart rate, central venous pressure, GEF and EVLWI did<br />

not change significantly. Stroke volume variation (SVV)<br />

also did not change significantly (10 ± 6, 10 ± 6, and<br />

11 ± 6%).<br />

However, ITBVI and GEDVI significantly increased<br />

during the intervention (Table 1). Overall stability of<br />

measurements was confirmed, as the coefficients of variation<br />

(SD/mean) for cardiac output, ITBVI and EVLWI<br />

at the three time points were: 4.7 ± 2.6, 6.3 ± 3.7, and


Table 1 Hemodynamic parameters<br />

Parameter Baseline Intervention Control<br />

HR (1/min) 98 ± 19 (100) 95 ± 17 (94) 94 ± 19 (95)<br />

CVP (mmHg) 12 ± 5 (12) 13 ± 7 (13) 12 ± 5 (13)<br />

CI (l/min/m 2 ) 3.3± 0.9 (3.4) 3.4 ± 0.9 (3.6) ∗ 3.3 ± 0.9 (3.3)<br />

SVR (dyn ∗ s ∗ cm −5 ) 551 ± 106 (535) 746 ± 91 (759) ∗ 566 ± 138 (525)<br />

GEF (%) 22 ± 6 (22) 22 ± 6 (23) 23 ± 7 (22)<br />

GEDVI (ml/m 2 ) 703 ± 178 (705) 747 ± 175 (761) ∗ 704 ± 170 (696)<br />

ITBVI (ml/m 2 ) 816 ± 203 (827) 867 ± 195 (915) ∗ 821 ± 205 (853)<br />

EVLWI (ml/kg) 7.0 ± 2.7 (7.0) 7.5 ± 3.0 (7.0) 7.4 ± 3.0 (7.0)<br />

Values are mean ± standard deviation (median).<br />

HR, Heart rate; CVP, central venous pressure; CI, cardiac index; SVR, systemic vascular resistance; GEF, global ejection fraction; GEDVI,<br />

global end-diastolic volume index; ITBVI, intrathoracic blood volume index; EVLWI, extravascular lung water index.<br />

∗ p < 0.05, ANOVA on ranks with a post-hoc all-pairwise comparison procedure (Student–Keuls)<br />

Fig. 1 a Linear regression<br />

analysis between changes in left<br />

ventricular end-diastolic area<br />

(LVEDA) and changes in global<br />

end-diastolic volume (GEDV).<br />

Line of regression is bold; 95%<br />

confidence intervals are<br />

indicated by the dashed lines.<br />

r =0.59(p = 0.02). b Linear<br />

regression analysis between<br />

changes in left-ventricular<br />

end-diastolic area (LVEDA)and<br />

changes in intrathoracic blood<br />

volume (ITBV). Line of<br />

regression is bold; 95%<br />

confidence intervals are<br />

indicated by the dashed lines.<br />

r =0.66(p = 0.005)<br />

4.9 ± 2.7%; 5.0 ± 2.5, 6.2 ± 4.0, and 4.9 ± 2.6 %; and<br />

5.6 ± 3.9, 6.0 ± 4.8, and 6.8 ± 4.0%, respectively.<br />

Transesophageal echocardiography (n = 8) revealed<br />

that LVEDA index changed from 10.4 ± 4.7 to<br />

12.4 ± 3.8 cm 2 /m 2 and finally to 9.7 ± 3.3 cm 2 /m 2<br />

(p < 0.05). In these patients, left-ventricular fractional<br />

area change (LV-FAC) was unchanged, i.e., it went from<br />

37 ± 12% to 36 ± 12% and 38 ± 11%. Both changes<br />

in GEDV and changes in ITBV were correlated with<br />

changes in LVEDA (Fig. 1). In these eight patients,<br />

PCCO also reversibly increased (6.4 ± 1.9, 7.3 ± 2.3, and<br />

6.2 ± 2.1 l/min) (not significantly different between the<br />

three different time points).<br />

Discussion<br />

We found that an acute increase in SVR by increasing<br />

norepinephrine dosage results in a reversible increase in<br />

transpulmonary thermodilution technique-derived central<br />

blood volumes, i.e., ITBVI and GEDVI.<br />

Both GEDVI and ITBVI are used as indicators of<br />

cardiac preload. However, GEDVI may be obtained from<br />

single transpulmonary thermodilution and allows calculation<br />

of ITBVI, which normally requires the thermo-dye dilution<br />

technique. According to experimental and clinical<br />

studies, ITBV can be derived accurately from GEDV by<br />

using a defined algorithm [1, 2].<br />

In principle, ITBV is calculated by using cardiac<br />

output and the issue of mathematical coupling has been<br />

raised previously. However, changes in cardiac output per<br />

se do not influence measurements of ITBV [11]. While<br />

cardiac output significantly increased during dobutamine<br />

(by 31.7%), ITBV remained unchanged (mean increase<br />

2.84%) [12]. Also, β-blockade caused substantial alterations<br />

in cardiac output which were not associated with<br />

changes in ITBV. Because hemodynamic changes were<br />

induced by factors other than variation of preload, these<br />

findings suggest that changes in cardiac output do not<br />

influence thermodilution measurements of ITBV and<br />

EVLW. As demonstrated in animals [13], dobutamine<br />

infusion increased CI by 30% while ITBV remained<br />

unchanged. In summary, the CI/GEDVI measures are<br />

mathematically coupled but this does not exclude noncoupled,<br />

physiologically independent variance, and this is<br />

what our study demonstrates again.


ITBV has been found to correlate well with cardiac<br />

volumes and its changes are better correlated with changes<br />

in cardiac volumes than are the filling pressures [13, 15,<br />

16]. Hinder et al. [9] described that changes in ITBV are<br />

well correlated with changes in LVEDA. These echocardiographic<br />

findings may be interpreted as supporting<br />

thermodilution-derived measurements. Furthermore, in<br />

patients with preserved left–right ventricular function [10]<br />

GEDV was found to give a reliable reflection of echocardiographic<br />

changes in left-ventricular preload following<br />

fluid loading.<br />

With respect to assessment of myocardial contractility,<br />

GEF has been found to provide reliable estimation of leftventricular<br />

systolic function but may underestimate it in<br />

the case of isolated right ventricular failure [17]. In our<br />

study, the increase in cardiac volumes was associated with<br />

a significant increase in cardiac output, as expected from<br />

the Frank–Starling law. Thus, GEF was unchanged and this<br />

was confirmed by LV-FAC.<br />

Finally, although the difference was not statistically<br />

significant, also PCCO showed a reversible increase in CO<br />

in our study. So far, pulse contour-derived cardiac output<br />

has been shown to remain reliable during increasing SVR<br />

(using phenylephrine and reversibly increasing MAP<br />

from 68 ± 6to95± 9 mmHg) [18]. In contrast, we used<br />

norepinephrine which is not a pure α-agonist but has<br />

α- andβ-adrenergic properties, because it is the first-line<br />

vasopressor agent in our department.<br />

References<br />

1. Neumann P (1999) Extravascular<br />

lung water and intrathoracic blood<br />

volume: double versus single indicator<br />

dilution technique. Intensive Care Med<br />

25:216–219<br />

2. Sakka SG, Ruhl CC, Pfeiffer UJ,<br />

Beale R, McLuckie A, Reinhart K,<br />

Meier-Hellmann A (2000) of cardiac<br />

preload and extravascular lung water by<br />

single transpulmonary thermodilution.<br />

Intensive Care Med 26:180–187<br />

3. Lichtwarck-Aschoff M, Zeravik J,<br />

Pfeiffer UJ (1992) Intrathoracic blood<br />

volume accurately reflects circulatory<br />

volume status in critically ill patients<br />

with mechanical ventilation. Intensive<br />

Care Med 18:142–147<br />

4. Sakka SG, Bredle DL, Reinhart K,<br />

Meier-Hellmann A (1999) Comparison<br />

between intrathoracic blood volume<br />

and cardiac filling pressures in the early<br />

phase of hemodynamic instability of<br />

patients with sepsis or septic shock.<br />

J Crit Care 14:78–83<br />

Our study has several limitations. First, we did not<br />

use the transpulmonary double-indicator technique, which<br />

may be regarded as the clinical reference standard.<br />

Furthermore, one could speculate that an acute increase<br />

in SVR might produce differential effects on cardiac<br />

dimensions depending on basal cardiac function. Unfortunately,<br />

our data are too limited to allow such an analysis.<br />

Although merely two-dimensional echocardiography was<br />

used to assess left-ventricular volume and not volumes<br />

of all cardiac (i.e., right heart) chambers, we found<br />

a similar change in LVEDA and central blood volumes<br />

during increase in SVR. Probably, determination of whole<br />

cardiac blood volume by magnetic resonance imaging<br />

or radionuclide techniques would give more insight.<br />

However, we decided to use a clinical monitoring system<br />

since the above-mentioned techniques are not practicable<br />

in the routine ICU setting.<br />

Conclusion<br />

5. Godje O, Peyerl M, Seebauer T,<br />

Lamm P, Mair H, Reichart B (1998)<br />

Central venous pressure, pulmonary<br />

capillary wedge pressure and intrathoracic<br />

blood volumes as preload<br />

indicators in cardiac surgery patients.<br />

Eur J Cardiothorac Surg 13:533–539<br />

6. Hoeft A, Schorn B, Weyland A,<br />

Scholz M, Buhre W, Stepanek E,<br />

Allen SJ, Sonntag H (1994) Bedside assessment<br />

of intravascular volume status<br />

in patients undergoing coronary bypass<br />

surgery. Anesthesiology 81:76–86<br />

7. Mitchell JP, Schuller D, Calandrino FS,<br />

Schuster DP (1992) Improved outcome<br />

based on fluid management in critically<br />

ill patients requiring pulmonary artery<br />

catheterization. Am Rev Respir Dis<br />

145:990–998<br />

8. Eisenberg PR, Hansbrough JR,<br />

Anderson D, Schuster DP (1987)<br />

A prospective study of lung water measurement<br />

during patient management in<br />

an intensive care unit. Am Rev Respir<br />

Dis 136:662–668<br />

An acute increase in systemic vascular resistance by<br />

increasing norepinephrine dosage results in a reversible<br />

increase in central blood volumes (ITBV, GEDV) as measured<br />

by the transpulmonary thermodilution technique.<br />

These findings are supported insofar as two-dimensional<br />

transesophageal echocardiography revealed an increase in<br />

LVEDA.<br />

9. Hinder F, Poelaert JI, Schmidt C,<br />

Hoeft A, Mollhoff T, Loick HM,<br />

Van Aken H (1998) Assessment of<br />

cardiovascular volume status by transoesophageal<br />

echocardiography and<br />

dye dilution during cardiac surgery. Eur<br />

J Anaesthesiol 15:633–640<br />

10. Hofer CK, Furrer L, Matter-Ensner S,<br />

Maloigne M, Klaghofer R, Genoni M,<br />

Zollinger A (2005) Volumetric preload<br />

measurement by thermodilution:<br />

a comparison with transoesophageal<br />

echocardiography. Br J Anaesth<br />

94:748–755<br />

11. Buhre W, Kazmaier S, Sonntag H,<br />

Weyland A (2001) Changes in cardiac<br />

output and intrathoracic blood volume:<br />

a mathematical coupling of data? Acta<br />

Anaesthesiol Scand 45:863–867<br />

12. McLuckie A, Bihari D (2000) Investigating<br />

the relationship between<br />

intrathoracic blood volume index and<br />

cardiac index. Intensive Care Med<br />

26:1376–1378


13. Lichtwarck-Aschoff M, Beale R, Pfeiffer<br />

UJ (1996) Central venous pressure,<br />

pulmonary artery occlusion pressure,<br />

intrathoracic blood volume, and right<br />

ventricular end-diastolic volume as<br />

indicators of cardiac preload. J Crit<br />

Care 11:180–188<br />

14. Buhre W, Weyland A, Schorn B,<br />

Scholz M, Kazmaier S, Hoeft A,<br />

Sonntag H (1999) Changes in central<br />

venous pressure and pulmonary capillary<br />

wedge pressure do not indicate<br />

changes in right and left heart volume<br />

in patients undergoing coronary artery<br />

bypass surgery. Eur J Anaesthesiol<br />

16:11–17<br />

15. Sakka SG, Bredle DL, Reinhart K,<br />

Meier-Hellmann A (1999) Comparison<br />

between intrathoracic blood volume<br />

and cardiac filling pressures in the early<br />

phase of hemodynamic instability of<br />

patients with sepsis or septic shock.<br />

J Crit Care 14:78–83<br />

16. Lichtwarck-Aschoff M, Zeravik J,<br />

Pfeiffer UJ (1992) Intrathoracic blood<br />

volume accurately reflects circulatory<br />

volume status in critically ill patients<br />

with mechanical ventilation. Intensive<br />

Care Med 18:142–147<br />

17. Combes A, Berneau JB, Luyt CE,<br />

Trouillet JL (2004) Estimation of<br />

left ventricular systolic function by<br />

single transpulmonary thermodilution.<br />

Intensive Care Med 30:1377–1383<br />

18. Weissman C, Ornstein EJ, Young WL<br />

(1993) Arterial pulse contour analysis<br />

trending of cardiac output: hemodynamic<br />

manipulations during cerebral<br />

arteriovenous malformation resection.<br />

J Clin Monit 9:347–353

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!